Asahi Kasei releases transcript from Q1 FY2026 financial results briefing Q&A session

Reuters2026/08/12 02:53

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Asahi Kasei released a Q&A transcript from its Q1 fiscal 2026 financial results briefing attended by CFO Toshiyasu Horie.
Horie signaled operating income likely to beat the prior full-year forecast of JPY 248 billion; forecast review set for November.
Management flagged a Q1 inventory valuation gain of slightly above JPY 20 billion, about 90% from Essential Chemical; Q2 seen negative JPY 10 billion.
Tarpeyo sales growth outlook trimmed to high teens to around 20% from 20%-30% on a U.S. dollar basis due to a temporary U.S. sales-staff shortfall.
Aicuris deal impact expected less negative than forecast; Prevymis royalties tracking above plan; pritelivir launch timing still around Q3 with under JPY 1 billion H2 sales.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Asahi Kasei Corporation published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Asahi Kasei releases transcript from Q1 FY2026 financial results briefing Q&A session

You may also like

Crypto prices